Clinical Trials Directory

Trials / Completed

CompletedNCT04442633

Glutamine With Topical Corticosteroids for Lichen Planus Treatment

Clinical Evaluation of Glutamine Combined With Topical Corticosteroids in the Treatment of Erosive Oral Lichen Planus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Glutamine promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.

Detailed description

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Recently, increased oxidative stress has been implicated in the pathogenesis of erosive oral lichen planus (EOLP). Glutamine is a source of energy for fibroblasts, immunocompetent cells, and intestinal epithelial cells involved in collagen production. It promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure. The aim of this study is to evaluate the effect of Glutamine combined with topical corticosteroid in the treatment of oral erosive LP. Thirty patients with a confirmed clinical and histopathologic diagnosis of OLP recruited in this study and divided into 2 equal groups, each consisting of 15 subjects. Group 1 consists of patients treated with topical steroids plus antifungal (conventional therapy); Group 2 consists of patients treated with Glutamine combined with topical steroids plus antifungal.

Conditions

Interventions

TypeNameDescription
DRUGGlutamine Cap/TabGlutamine Capsules: One capsule three times daily on an empty stomach for one month
DRUGMiconazole Oral gelMiconazole oral gel: applied three to four times daily for three weeks
DRUGKenacort in orabaseKenacort in orabase: applied two to three times a day for 3 weeks followed by tapering the following 9 weeks until a maintenance dose of two to three times a week is reached

Timeline

Start date
2019-04-01
Primary completion
2019-08-01
Completion
2020-01-01
First posted
2020-06-22
Last updated
2020-06-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04442633. Inclusion in this directory is not an endorsement.